Q: What's the caveat of diagnosing HIV in patients who are using pre-exposure prophylaxis (PrEP) for HIV?
Answer: Unreliable clinical signs and routine HIV screening test
Patients who are on pre-exposure prophylaxis (PrEP) due to their lifestyle may not develop full-blown acute HIV symptoms on initial contraction, but may have mild symptoms called pauci-symptomatic acute HIV. Cardinal acute HIV symptoms such as fever and rash are usually absent, and there may be no pharyngitis or diarrhea. To make things more complicated, routine HIV screening with the antigen/antibody test may not be reliable. Diagnosis can be made by history, exposure, keeping a high clinical suspicion, and HIV RNA as the screening tool.
#ID
References:
1. Landovitz RJ, Delany-Moretlwe S, Fogel JM, et al. Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis. N Engl J Med 2024; 391:1253.
2. Moschese D, Lazzarin S, Colombo ML, Caruso F, Giacomelli A, Antinori S, Gori A. Breakthrough Acute HIV Infections among Pre-Exposure Prophylaxis Users with High Adherence: A Narrative Review. Viruses. 2024 Jun 12;16(6):951. doi: 10.3390/v16060951. PMID: 38932243; PMCID: PMC11209220.
3. Elliott T, Sanders EJ, Doherty M, Ndung'u T, Cohen M, Patel P, Cairns G, Rutstein SE, Ananworanich J, Brown C, Fidler S. Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review. J Int AIDS Soc. 2019 Dec;22(12):e25419. doi: 10.1002/jia2.25419. PMID: 31850686; PMCID: PMC6918508.


